Barely Significant
← all phrases

“near-significant”

2,307 sentences · 2,307 papers · 5,465 search hits before verification · confirmed specimen

Listed by Otte et al. (2022)

In the literature

The final library (KO-Library 4) targets 522 genes with significant or near-significant effects on LDL-C uptake from the three previous screens as well as from a published genome-wide LDL-C uptake CRISPR-Cas9 screen performed in Huh7 cells. 22 Altogether, the four screens identify a total of 490 genes whose knockout alters LDL-C uptake under either SER or SS conditions (299 decrease u
Patients with a low SBM frequency at baseline, i.e., women, older people, and patients without overweight, with a long duration of constipation, and with autonomic neuropathy and sensory neuropathy, showed a significant (ESM Tables S1, S2, S3, and S4) or near-significant (ESM Table S5 and S6) increase in SBM frequency.
Normalized cortical volume was significantly lower on RIS group compared with healthy controls (673 ± 27.07 vs 641 ± 35.88 (cm 3 × 10 3 ), Tukey P test = 0.009), whereas near-significant difference was observed between CIS and healthy control groups (648 ± 27.34 vs 673 ± 27.07 (cm 3 × 10 3 ), Tukey P test = 0.057).
Gray Matter Involvement in Radiologically Isolated Syndrome.
Medicine (Baltimore) · 2016 · PMC4998546
Older age at the time of primary surgery was associated with a higher risk of reoperation (OR per year = 1.261; p = 0.024), independent of follow-up duration, which was uniform across the cohort Preoperative occlusion therapy ( p = 0.075) and age at surgery ( p = 0.055) demonstrated near-significant trends but did not meet the pre-defined significance threshold.
Our finding that no distinguishable differences in physiological measurements were observed, aside from a near-significant effect of SOLF diet leading to decreased glucose levels, over the course of the study suggest that we have captured an early stage of diet intervention which, if continued over time, might result in measurable changes in metabolic health.
raised concerns regarding the integrity of the randomization process, as evidenced by near-significant differences in baseline characteristics between groups – the S. repens treatment group had almost statistically worse prostate volume, Charlson Comorbidity Index, and urinary symptoms than the Prostaflog group – as well as unexplained discrepancies in group sample sizes. 44 In our opinion, these methodological shortcomings necessitated the exclusion of these studies from the primary analysis in order to preserve the rigour and credibility of our conclusions.
Raloxifene was associated with a statistically significant difference in follicle-stimulating hormone based on a treatment by sex analysis and a trend towards significant differences in prothrombin time and anti-thrombin III (see Supplementary Table S1 for details); however, these statistically significant or near-significant changes with raloxifene treatment were determined to not be clinically relevant.